MétaCan
Menu
Back to cohort
Record W4416221126 · doi:10.1302/1358-992x.2025.13.037

PRECLINICAL MODEL OF OSTEOBLASTIC-OSTEOLYTIC BONE METASTASES DEMONSTRATES SARCOPENIA WITH IMAGING BIOMARKERS

2025· article· en· W4416221126 on OpenAlexaff
Liza Abraham, Azin Mirzajavadkhan, Christine Huang, Cari Whyne, Michael Hardisty, Margarete K. Akens

Bibliographic record

VenueOrthopaedic Proceedings · 2025
Typearticle
Languageen
FieldMedicine
TopicBone health and treatments
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsSarcopeniaProstate cancerZoledronic acidDocetaxelProstateOsteoporosisAtrophyMuscle atrophyCancer

Abstract

fetched live from OpenAlex

Metastasized cancer cells disturb bone remodeling, leading to an increased formation of low-quality bone. In addition to changes to the bone, 61% of patients with prostate cancer experience sarcopenia (generalized muscle weakening). Systemic treatment with docetaxel (DTX) and bisphosphonates [Zoledronic Acid (ZA)] for prostate cancer are known to have an impact on musculoskeletal health. Research on the relationship between the atrophy of both tissues, known as osteosarcopenia, has been limited. This increases the frequency of falls and fractures, and an overall lowered quality of life. This study aims to determine imaging biomarkers from the psoas muscle in the presence of metastatic prostate cancer. Twenty-four athymic, 5-week-old male rats were randomly assigned to the following groups: healthy control, healthy treated, ACE-1 cell injected control, and ACE-1 cell injected treated. Institutional approval was obtained, and the ARRIVE guidelines were followed. Under anaesthesia 19 rats received an intra-cardiac injection of luciferase-transfected ACE-1 canine prostate cancer cells (1.5x106 cells/200 µL). Grip strength tests (Grip Strength Test, Bioseb), µMRI (NanoScan, Mediso, with Gadolinium contrast), µCT (NanoScan, Mediso), and bioluminescence imaging (IVIS Spectrum) monitored muscle and bone changes (Figure 1). Rats were injected with docetaxel (5 mg/kg,i.v), or zoledronic acid (Zometa; 60µg/kg, s.c.) on day 9 post-tumour cell injection. All animals tolerated the procedures well. The rats were sacrificed on day 21, for ex-vivo vertebral imaging using high-resolution μCT (µCT100, Scanco, 34.4µm isotropic voxels) to assess trabecular bone architectural properties. Psoas muscles were manually segmented from fused in-vivo MR/CT images to investigate imaging biomarkers like muscle L2-normalized-psoas-volume and attenuation (Figure 2). Bioluminescence and ex-vivo µCT images confirmed mixed metastases in 9 rats (Figure 1). The presence of sarcopenia in rats with metastatic disease was confirmed by a significantly lower normalized psoas volume in cell-injected animals compared to healthy animals (p Sarcopenia was observed with imaging biomarkers of muscle volume and attenuation in this preclinical model of bone metastases secondary to prostate cancer. This study will provide a more thorough understanding of the relationship between treatments, osteopenia, and prostate cancer tumour burden. The imaging biomarkers evaluated in this study may facilitate the earlier diagnosis of osteosarcopenia in prostate cancer patients, leading to earlier intervention and increasing the quality of life. For any figures or tables, please contact the authors directly.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.405
Threshold uncertainty score0.846

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.300
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueOrthopaedic ProceedingsSame topicBone health and treatmentsFrench-language works237,207